No image

Access CEA QC

The Access CEA QC (BSA matrix) controls are intended for monitoring the system performance of immunoenzymatic procedures for the quantitative measurement of Carcinoembryonic Antigen (CEA) using Access CEA reagents.

Details

Device typeCarcinoembryonic antigen (CEA) IVD, kit, chemiluminescent immunoassay: A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of carcinoembryonic antigen (CEA) in a clinical specimen, using a chemiluminescent immunoassay method.

FDA categorySystem, Test, Carcinoembryonic Antigen

Device ID15099590624811

Catalog number33209

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Contact

No contact is listed for this device.

Related products

Product	Model	Company	Device type
CEA-NG AccuBind ELISA Test System - 192 WellsMonobind, Inc.Carcinoembryonic antigen (CEA) IVD, kit, enzyme immunoassay (EIA)	4625-300	Monobind, Inc.	Carcinoembryonic antigen (CEA) IVD, kit, enzyme immunoassay (EIA)
Access C-PeptideBeckman Coulter, Inc.C-peptide IVD, kit, chemiluminescent immunoassay	C33451	Beckman Coulter, Inc.	C-peptide IVD, kit, chemiluminescent immunoassay
Elecsys CA 15-3 IIRoche Diagnostics GmbHCancer antigen 15-3 (CA15-3) IVD, kit, enzyme immunoassay (EIA)	09755594190	Roche Diagnostics GmbH	Cancer antigen 15-3 (CA15-3) IVD, kit, enzyme immunoassay (EIA)
ARCHITECTAbbott GmbHCancer antigen 15-3 (CA15-3) IVD, kit, chemiluminescent immunoassay	02K4437	Abbott GmbH	Cancer antigen 15-3 (CA15-3) IVD, kit, chemiluminescent immunoassay